Pursuant to section 106 (1) of the Medicines Act 1981,
I, G. R. Boyd, Chief Advisor, Public Health Safety and Regulation, acting under delegated authority, hereby declare the following:
1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
2. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) preparations and admixtures containing any substance listed in the notice;
(b) salts and esters of any substance listed in the notice;
(c) preparations or extracts of biological materials listed in the notice;
(d) salts or oxides of elements listed in the notice.
Unless specific reference is made otherwise, every reference to a medicine also applies:
(i) in the case of medicines which are injections or eye preparations, to any concentration of that medicine;
(ii) in the case of medicines which are not injections or eye preparations, when the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using
the free acid, base, alcohol or element unless specifically stated otherwise.
Schedule 1
Prescription Medicines
Agalsidase
Atosiban
Bimatoprost
Dibotermin
Dutasteride
Eflornithine
Escitalopram
Etoricoxib
Factor VIII inhibitor bypassing fraction
Fondaparinux
Imatinib
Levocetirizine; except for oral use
Methyl aminolevulinate
Olopatadine
Parecoxib
Peginterferon
Pimecrolimus
Rasburicase
Rosuvastatin
Tadalafil
Teriparatide
Travoprost
Valdecoxib
Valganciclovir
Schedule 3
Pharmacy-only Medicine
Levocetirizine; for oral use
Dated this 6th day of March 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on 20 February 1997).